Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James L. Stanton is active.

Publication


Featured researches published by James L. Stanton.


Tetrahedron Letters | 1997

The use of thioesters in solid phase organic synthesis

Isidoros Vlattas; James Dellureficio; Robert Dunn; Iou Iou Sytwu; James L. Stanton

Abstract Mercaptan-resin linkers are used for the synthesis of C-terminal thioesters which are then cleaved with alcohols, amines and organometallic reagents to generate esters, amides, ketones, aldehydes and alcohols as the final products of solid phase synthesis.


Bioorganic & Medicinal Chemistry Letters | 2000

Synthesis and biological activity of phenoxyphenyl oxamic acid derivatives related to L-thyronine.

James L. Stanton; Edna Cahill; Ronald Dotson; Jenny Tan; Hollis C. Tomaselli; Jong M. Wasvary; Zouhair F. Stephan; Ronald E. Steele

The synthesis of substituted phenoxyphenyl oxamic acid derivatives related to L-thyronine (L-T3) is described. The in vitro and in vivo cholesterol lowering and cardiovascular effects of these compounds are presented and discussed.


Bioorganic & Medicinal Chemistry Letters | 1994

The effect of heteroatom substitution on a series of phosphonate inhibitors of neutral endopeptidase 24.11

James L. Stanton; Gary Michael Ksander; Reynalda de Jesus; Donald Mark Sperbeck

Abstract A series of phosphonic acids, 7a–d, with heteroatom and carbon variations in the template backbone were prepared and tested for inhibition of neutral endopeptidase 24.11. The structure-activity relationship of these derivatives is presented and discussed.


Archive | 2004

Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1

Gary Mark Coppola; Robert E. Damon; Paivi Jaana Kukkola; James L. Stanton


Journal of Medicinal Chemistry | 1988

Synthesis and biological activity of some transition-state inhibitors of human renin

Bühlmayer P; Caselli A; Walter Fuhrer; Richard Goschke; Rasetti; Rüeger H; James L. Stanton; Leoluca Criscione; Jeanette Marjorie Wood


Journal of Medicinal Chemistry | 1985

Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.

Jeffrey W. H. Watthey; James L. Stanton; Mahesh Desai; Joseph E. Babiarz; Barbara M. Finn


Journal of Enzyme Inhibition | 1987

Inhibitors of renin as potential therapeutic agents.

Jeanette Marjorie Wood; James L. Stanton; Karl G. Hofbauer


Journal of Medicinal Chemistry | 1985

Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives

Joel Slade; James L. Stanton; Daniel Ben-David; Gerard C. Mazzenga


Journal of Heterocyclic Chemistry | 1981

The synthesis of pyridine derivatives from 3‐formylchromone

James L. Stanton; Andreas von Sprecher; Paul Wenk


Journal of Medicinal Chemistry | 2000

Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.

Gregory Raymond Bebernitz; Thomas Daniel Aicher; James L. Stanton; Jiaping Gao; Suraj Shivappa Shetty; Douglas C. Knorr; Robert J. Strohschein; Jennifer Tan; Leonard Brand; Charles Z. Liu; Wei H. Wang; Christine C. Vinluan; Emma L. Kaplan; Carol J. Dragland; Dominick DelGrande; Amin Islam; Robert J. Lozito; Xilin Liu; Wieslawa M. Maniara; William R. Mann

Collaboration


Dive into the James L. Stanton's collaboration.

Researchain Logo
Decentralizing Knowledge